Wuhan Gleifly Pharmaceutical Technology Co., Ltd.

Wuhan Gleifhi Pharmaceutical Technology Co., Ltd. was established on September 27, 2016. Its legal representative is Huang Xiuquan. Its registered capital is RMB 1 million. Its unified social credit code is 91420115MA4KNL0K9T. Its corporate address is located at No. N1101-1102, Zone B, Free Trade Bio-Innovation Port, No. 777, Guanggu 3rd Road, East Lake New Technology Development Zone, Wuhan (Wuhan Area of ​​Free Trade Zone). Its industry is research and experimental development. Its business scope includes: Licensed projects: import and export of goods (projects that must be approved according to law can only be carried out after approval by relevant departments. The specific business projects are subject to the approval documents or licenses of relevant departments) General projects: R&D of biochemical product technology; manufacturing of special chemical products (excluding hazardous chemicals); sales of special chemical products (excluding hazardous chemicals); technical services, technical development, technical consultation, technical exchanges, technology transfer, and technology promotion (except for projects that must be approved according to law, business activities are carried out independently in accordance with the law with a business license). The current business status of Wuhan Gleifhi Pharmaceutical Technology Co., Ltd. is ongoing (in operation, open for business, and registered).